耐甲氧西林金黄色葡萄球菌菌血症的治疗
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
作者信息
Choo Eun Ju, Chambers Henry F
机构信息
Division of Infectious Diseases, Department of Medicine, Soonchunhyang University Hospital, Bucheon, Korea.
Division of Infectious Diseases, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA, USA.
出版信息
Infect Chemother. 2016 Dec;48(4):267-273. doi: 10.3947/ic.2016.48.4.267.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a significant cause of health care-associated infections. Vancomycin remains an acceptable treatment option. There has been a welcome increase in the number of agents available for the treatment of MRSA infection. These drugs have certain differentiating attributes and may offer some advantages over vancomycin, but they also have significant limitations. These agents provide some alternative when no other options are available.
摘要
耐甲氧西林金黄色葡萄球菌（MRSA）是医疗保健相关感染的一个重要原因。万古霉素仍然是一种可接受的治疗选择。可用于治疗MRSA感染的药物数量有所增加，这是值得欢迎的。这些药物具有某些不同的特性，可能比万古霉素有一些优势，但它们也有显著的局限性。当没有其他选择时，这些药物提供了一些替代方案。
相似文献
1
Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.耐甲氧西林金黄色葡萄球菌菌血症的治疗
Infect Chemother. 2016 Dec;48(4):267-273. doi: 10.3947/ic.2016.48.4.267.
2
Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.预测金黄色葡萄球菌菌血症患者的耐甲氧西林情况及经验性治疗不足对生存的影响。
Arch Intern Med. 2000 Apr 10;160(7):1001-4. doi: 10.1001/archinte.160.7.1001.
3
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: New Therapeutic Approaches.耐甲氧西林金黄色葡萄球菌引起的菌血症：新的治疗方法
Infect Dis Clin North Am. 2016 Jun;30(2):491-507. doi: 10.1016/j.idc.2016.02.009.
4
Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond.耐甲氧西林金黄色葡萄球菌的治疗：万古霉素及其他。
Semin Respir Crit Care Med. 2015 Feb;36(1):17-30. doi: 10.1055/s-0034-1397040. Epub 2015 Feb 2.
5
A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.一项关于万古霉素与达托霉素治疗万古霉素最低抑菌浓度较高的耐甲氧西林金黄色葡萄球菌菌血症的随机2B期试验——一项提前终止研究的结果
Trials. 2018 Jun 1;19(1):305. doi: 10.1186/s13063-018-2702-8.
6
Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.使用耐甲氧西林金黄色葡萄球菌筛查试验预测金黄色葡萄球菌菌血症中的甲氧西林耐药性。
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7444-7448. doi: 10.1128/AAC.01751-16. Print 2016 Dec.
7
Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.用达托霉素治疗的耐甲氧西林金黄色葡萄球菌人工主动脉瓣心内膜炎合并瓣周脓肿
Heart Lung. 2005 Jan-Feb;34(1):69-71. doi: 10.1016/j.hrtlng.2004.07.009.
8
Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.头孢洛林酯单药治疗耐甲氧西林金黄色葡萄球菌菌血症：一项比较临床结局研究。
Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.
9
Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.耐甲氧西林金黄色葡萄球菌菌血症在血液透析和非血液透析患者中的表现。
J Microbiol Immunol Infect. 2014 Feb;47(1):15-22. doi: 10.1016/j.jmii.2012.08.015. Epub 2012 Oct 3.
10
A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. stewardship 项目回顾性评估耐甲氧西林金黄色葡萄球菌菌血症和骨髓炎患者的万古霉素 AUC24/MIC 和微生物学清除时间。
Clin Ther. 2013 Jun;35(6):772-9. doi: 10.1016/j.clinthera.2013.05.008.
引用本文的文献
1
Differentiating bacteria by their unique surface interactions.通过细菌独特的表面相互作用对其进行区分。
PLoS One. 2025 Jun 30;20(6):e0327489. doi: 10.1371/journal.pone.0327489. eCollection 2025.
2
: A Review of the Pathogenesis and Virulence Mechanisms.发病机制与毒力机制综述
Antibiotics (Basel). 2025 May 6;14(5):470. doi: 10.3390/antibiotics14050470.
3
The Ligand Binding Domain of the Cell Wall Protein SraP Modulates Macrophage Apoptosis and Inflammatory Responses in Infections.细胞壁蛋白SraP的配体结合结构域在感染中调节巨噬细胞凋亡和炎症反应。
Molecules. 2025 Mar 5;30(5):1168. doi: 10.3390/molecules30051168.
4
Risk of Postoperative Infection in Total Knee Arthroplasty Patients with Preoperative Methicillin-Resistant (MRSA) Colonization.术前耐甲氧西林（MRSA）定植的全膝关节置换术患者术后感染的风险
J Clin Med. 2025 Jan 24;14(3):765. doi: 10.3390/jcm14030765.
5
Exploring caffeine as a disruptor of membrane integrity and genomic stability in Staphylococcus aureus: functional and in silico analysis.探索咖啡因作为金黄色葡萄球菌膜完整性和基因组稳定性的破坏剂：功能分析和计算机模拟分析
Arch Microbiol. 2025 Jan 8;207(2):28. doi: 10.1007/s00203-024-04230-x.
6
An optimal antibiotic selection framework for Sepsis patients using Artificial Intelligence.一种使用人工智能的脓毒症患者最佳抗生素选择框架。
NPJ Digit Med. 2024 Nov 29;7(1):343. doi: 10.1038/s41746-024-01350-y.
7
PDADMAC/Alginate-Coated Gold Nanorod For Eradication of Staphylococcus Aureus Biofilms.聚二甲基二烯丙基氯化铵/藻酸盐涂层金纳米棒用于消除金黄色葡萄球菌生物膜。
Int J Nanomedicine. 2024 Apr 23;19:3697-3714. doi: 10.2147/IJN.S452085. eCollection 2024.
8
Recent Advances in the Development of Antibiotics-Coated Gold Nanoparticles to Combat Antimicrobial Resistance.用于对抗抗菌耐药性的抗生素包被金纳米颗粒的研发新进展
Antibiotics (Basel). 2024 Jan 26;13(2):124. doi: 10.3390/antibiotics13020124.
9
Population Pharmacokinetics and Model-Based Dose Optimization of Vancomycin in Sudanese Adult Patients with Renal Impairment.人群药代动力学和基于模型的优化方案在苏丹肾损伤成年患者中万古霉素的剂量。
Drug Des Devel Ther. 2024 Jan 16;18:81-95. doi: 10.2147/DDDT.S432439. eCollection 2024.
10
Nanosecond pulsed electric fields increase antibiotic susceptibility in methicillin-resistant .纳秒级脉冲电场提高耐甲氧西林金黄色葡萄球菌对抗生素的敏感性
Microbiol Spectr. 2024 Jan 11;12(1):e0299223. doi: 10.1128/spectrum.02992-23. Epub 2023 Dec 4.
本文引用的文献
1
Daptomycin-β-Lactam Combinations in a Rabbit Model of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Endocarditis.达托霉素不敏感的耐甲氧西林金黄色葡萄球菌心内膜炎兔模型中达托霉素与β-内酰胺类药物的联合应用
Antimicrob Agents Chemother. 2016 Jun 20;60(7):3976-9. doi: 10.1128/AAC.00589-16. Print 2016 Jul.
2
Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.万古霉素联合β-内酰胺类抗生素治疗耐甲氧西林金黄色葡萄球菌菌血症：一项多中心随机对照试验的初步研究。
Clin Infect Dis. 2016 Jan 15;62(2):173-180. doi: 10.1093/cid/civ808. Epub 2015 Sep 8.
3
Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.替拉万星：作用机制、体外活性和耐药机制。
Clin Infect Dis. 2015 Sep 15;61 Suppl 2:S58-68. doi: 10.1093/cid/civ534.
4
Comparative efficacies of tedizolid phosphate, vancomycin, and daptomycin in a rabbit model of methicillin-resistant Staphylococcus aureus endocarditis.磷酸特地唑胺、万古霉素和达托霉素在耐甲氧西林金黄色葡萄球菌心内膜炎兔模型中的疗效比较
Antimicrob Agents Chemother. 2015;59(6):3252-6. doi: 10.1128/AAC.04376-14. Epub 2015 Mar 23.
5
Ceftaroline Fosamil for the Treatment of Bacteremia Secondary to Acute Bacterial Skin and Skin Structure Infections or Community-Acquired Bacterial Pneumonia.头孢洛林酯用于治疗急性细菌性皮肤及皮肤结构感染或社区获得性细菌性肺炎继发的菌血症
Infect Dis Clin Pract (Baltim Md). 2015 Jan;23(1):39-43. doi: 10.1097/IPC.0000000000000191.
6
Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.头孢洛林酯氨噻肟挽救治疗：降低万古霉素敏感性金黄色葡萄球菌菌血症的一种选择。
J Antimicrob Chemother. 2015 Mar;70(3):797-801. doi: 10.1093/jac/dku455. Epub 2014 Nov 17.
7
Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.万古霉素最低抑菌浓度与金黄色葡萄球菌血流感染患者死亡率之间的关系：系统评价和荟萃分析。
JAMA. 2014 Oct 15;312(15):1552-64. doi: 10.1001/jama.2014.6364.
8
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance.替加环素的早期经验：临床疗效、药效学及耐药性
Pharmacotherapy. 2014 Nov;34(11):1198-208. doi: 10.1002/phar.1491. Epub 2014 Sep 30.
9
Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.使用达托霉素联合头孢洛林对持续性葡萄球菌菌血症进行抗菌挽救治疗。
Clin Ther. 2014 Oct 1;36(10):1317-33. doi: 10.1016/j.clinthera.2014.05.061. Epub 2014 Jul 10.
10
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study.替考拉宁与标准治疗方案用于非复杂性金黄色葡萄球菌菌血症患者的随机2期试验：ASSURE研究
BMC Infect Dis. 2014 May 23;14:289. doi: 10.1186/1471-2334-14-289.
Zotero 插件